Brinker Capital Investments, LLC Biogen Inc. Transaction History

Brinker Capital Investments, LLC

$5.01 Billion
Q4 2022

A detailed history of Brinker Capital Investments, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 7,975 shares of BIIB stock, worth $1.26 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,975

Previous 11,192 28.74%

Holding current value

$1.26 Million

Previous $2.99 Million 26.1%

% of portfolio

0.04%

Previous 0.06%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$252.44 - $306.72 $812,099 - $986,718	-3,217 Reduced 28.74%	7,975 $2.21 Million
Q3 2022 Nov 01, 2022	BUY	$194.69 - $268.46 $151,274 - $208,593	777 Added 7.46%	11,192 $2.99 Million
Q2 2022 Jul 18, 2022	BUY	$187.54 - $223.02 $601,065 - $714,779	3,205 Added 44.45%	10,415 $2.12 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $483,843 - $609,617	-2,497 Reduced 25.72%	7,210 $1.52 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $185,181 - $237,985	827 Added 9.31%	9,707 $2.33 Million
Q2 2021 Aug 03, 2021	BUY	$259.0 - $414.71 $105,931 - $169,616	409 Added 4.83%	8,880 $3.08 Million
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $1.76 Million - $2.06 Million	-7,231 Reduced 46.05%	8,471 $2.37 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1.89 Million - $2.85 Million	8,017 Added 104.32%	15,702 $3.85 Million
Q3 2020 Dec 03, 2020	BUY	$264.77 - $305.71 $2.03 Million - $2.35 Million	7,685 New	7,685 $2.18 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $52,425 - $66,502	-195 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$220.06 - $304.07 $880 - $1,216	4 Added 2.09%	195 $58,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $101,979 - $114,379	-469 Reduced 71.06%	191 $44,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $94,733 - $104,423	432 Added 189.47%	660 $154,000
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $46,375 - $72,537	214 Added 1528.57%	228 $54,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $3,605 - $4,296	14 New	14 $4,000
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $1,124 - $1,318	-4 Closed	0 $0
Q2 2017 Aug 08, 2017	BUY	N/A	4	4 $1,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account

Brinker Capital Investments, LLC Biogen Inc. Transaction History